微生物来源的HLE抑制剂N01WA-735E的研究

人白细胞弹性蛋白酶抑制剂为筛选炎症和癌症的重要靶点。应用白细胞弹性蛋白酶抑制剂高通量的筛选模型对数千株放线菌进行筛选,发现了阳性菌株N01WA-735。首先通过形态学和化学分类学鉴定其为链霉菌属。采用有机溶剂提取、硅胶柱色谱、Sephadex LH-20柱色谱和结晶等方法对该菌株的发酵产物进行了分离纯化,得到活性单体化合物N01WA-735E,通过对N01WA-735E的理化性质和波谱数据分析,确定其结构与文献报道的化合物BE-52440A相同。该化合物对人白细胞弹性蛋白酶有很强的抑制活性,其IC50为3.02μmol/L。该化合物对人白细胞弹性蛋白酶的抑制活性国内外未见报道。     

一种白僵菌中MAO抑制剂的分离纯化和结构鉴定

本研究对前期筛选出的一株具有较强的单胺氧化酶(MAO)抑制活性的白僵菌菌株Ba02进行了液体培养;通过不同提取剂的提取效果比较,发现乙酸乙酯能较好地提取出该发酵液中单胺氧化酶抑制剂。通过活性指导下的色谱分离,从乙酸乙酯提取物中得到了一种深红色粉末状化合物。活性测定结果显示该化合物在15μg.mL-1时对MAO-A和MAO-B的抑制率分别为97.50%和95.34%。MS和NMR的鉴定结果表明该化合物为卵孢菌素(Oosporein)。虽然该化合物是一已知化合物,但其对单胺氧化酶的抑制活性尚属首次发现。     

一株海洋真菌Penicillium sp.QF046的细菌群体感应抑制剂的分离和鉴定

目的:从海洋真菌中筛选得到新型群体感应抑制剂,并对其进行活性评价。方法:首先利用紫色杆菌CV026指示菌株对真菌发酵粗提物进行活性筛选。其次通过18S r DNA序列比对进行菌种鉴定,同时采用硅胶柱色谱、凝胶柱色谱和高效液相色谱等技术并结合活性追踪检测分离纯化的活性化合物,再通过核磁质谱分析确定其结构。最后利用定量测定方法检测其在亚抑菌浓度下对紫色杆菌紫色菌素产量影响以及RT-PCR检测与QS调控相关基因的m RNA表达的影响。结果:从海藻共生菌中筛选到一株具有紫色杆菌群体感应抑制活性的海洋真菌Penicillium sp.QF046,其次级代谢产物中纯化到的活性化合物根据结构鉴定为一种星形曲霉毒素(asteltoxin)。该化合物对于紫色杆菌群体感应抑制浓度低于阳性对照化合物呋喃酮C30,同时抑制了群体感应相关基因m RNA水平的表达。结论:从海洋真菌Penicillium sp.QF046代谢产物中发现了一种抑制紫色杆菌群体感应的星形曲霉毒素,为进一步通过结构改造研发新型抗菌药物提供良好的前体化合物。     

黄河三角洲耐盐真菌Penicillium chrysogenum HK14-01的次生代谢产物

【目的】从黄河三角洲耐盐微生物的代谢产物中寻找具有抗菌和抗肿瘤活性的化合物。【方法】应用化学与生物活性相集成的筛选方法,从耐盐微生物中筛选获得代谢产物丰富并具有生物活性的目标菌株;通过高盐胁迫目标菌株,利用硅胶柱色谱、凝胶柱色谱和高效液相色谱等方法对发酵产物进行分离、纯化,运用波谱解析、钼靶X-射线单晶衍射分析、圆二色散谱(CD)和密度泛函数(DFT)-ECD的计算鉴定化合物的结构。【结果】从采自黄河三角洲的泥土样品中得到一株耐盐真菌HK14-01,鉴定为产黄青霉Penicilliumchrysogenum;从其发酵产物中分离鉴定了8个化合物:(2S,3R)-oxaline(1,主产物)、(3R,4R)-3,4,8-trihydroxy-3,4-dihydronaphthalen-1(2H)-one(2)、(Z)-N-(4-hydroxystyryl)formamide(3)、(E)-N-(4-hydroxystyryl)formamide(4)、emodin(5)、4-(2-hydroxyethyl)benzene-1,2-diol(6)、methyl 2-(4-hydroxyphenyl)acetate(7)和2-(4-hydroxy phenyl)acetonitrile(8);化合物1、3和4对大肠杆菌以及化合物1和5对金黄色葡萄球菌表现出抑菌活性,化合物5对P388细胞表现出微弱的细胞增殖抑制活性。【结论】首次确定了化合物2的绝对构型、首次报道了化合物1和2的CD数据;从黄河三角洲的耐盐微生物的次生代谢产物中可以得到活性化合物,这一区域的耐盐微生物资源值得深入研究。     

一株银杏内生真菌菌株的抑菌活性成分研究

从银杏叶柄分离筛选到具抗菌活性的内生真菌Colletotrichum.SP NTB-2菌株,利用硅胶柱色谱、制备高效液相色谱等方法在其发酵产物中分离到抗枯草芽孢杆菌、鼠伤寒沙门氏菌等具有广谱抑菌活性的化合物,经MS、NMR等波谱数据确认该活性成分为芹菜素-8-C-葡萄糖苷(apigenin-8-C-β-D-glucopyranoside),该化合物首次从真菌中分离得到。     

盐地碱蓬内生菌Neocamarosporium sp. ZLM-26次级代谢产物

本研究对盐地碱蓬内生菌Neocamarosporium sp. ZLM-26的活性次级代谢产物进行了挖掘。采用薄层色谱、硅胶柱色谱、高效液相色谱等分离方法,从该菌株大米培养基发酵产物的乙酸乙酯萃取物中分离得到6个单体化合物,经波谱学解析和文献数据对比,鉴定6个化合物分别为：5-butyl-6-(hydroxymethyl)-2H-pyran-2-one(1)、(7S)-xylariolide E(2)、(6S)-xylariolide D(3)、diaporpyrone A(4)、4-hydroxybenzaldehyde(5)和2-(2-hydroxyethyl) phenol(6)。分别采用CCK-8法和96孔板法评估了6个化合物的抗肿瘤和抗菌活性。结果显示,6个化合物(50 μmol/L)对胰腺癌细胞株SW1990、PANC-1的增殖无明显抑制作用;而化合物4对大肠杆菌有较好的增殖抑制活性,化合物5、6对铜绿假单胞菌有较好的增殖抑制活性。化合物1为1个新的天然产物,本研究首次报道了其核磁数据和抗菌活性。此外,化合物1–4均为首次从新凸轮孢菌属真菌中分离得到。     

北桑寄生内生真菌的分离及其次级代谢产物分析

首次对药用植物北桑寄生叶片中的内生真菌进行分离纯化,从中筛选出具有较高生物活性的菌株,鉴定此菌株并对其次级代谢产物进行初步分离。采用组织块法分离内生真菌,对其进行抗氧化活性和抑菌活性筛选;通过形态学和分子生物学方法鉴定其种属;运用柱色谱、重结晶等方法分离次级代谢产物,波谱学鉴定其结构。从北桑寄生叶片中分离纯化得到29株内生真菌,检测得到一株具有较高抗氧化和抑菌活性的菌株,鉴定为Alternaria alternata,从该菌次级代谢产物中首次分离得到3个单体化合物,分别为alternariol-5-O-methyl ether(1)、alternariol(2)、cis,cis-9,12-octadecadienoic acid(3)。化合物1和2具有较弱的抗氧化活性,化合物1和3表现出一定的抑菌活性。     

青海干旱生境土壤链霉菌次级代谢产物的分离鉴定及活性研究北大核心CSCD

对青海干旱生境土壤链霉菌Streptomyces pactum KIB-HL8液体发酵,应用硅胶柱色谱和高效液相色谱等方法进行分离和纯化,得到5个化合物,并用MS、NMR等方法对其结构进行解析,分别鉴定为N-乙酰酪胺(1)、N-乙酰色胺(2)、吡咯-2-甲酰胺(3)、Inthomycin C(4)和Inthomycin B(5)。对其抗真菌、细菌活性进行筛选,发现化合物4对金黄色葡萄球菌有抑制活性,化合物1和2对番茄灰霉病菌有抑制活性,化合物3对番茄早疫病菌有较强的抑制活性。     

青海干旱生境土壤链霉菌次级代谢产物的分离鉴定及活性研究

对青海干旱生境土壤链霉菌Streptomyces pactum KIB-HL8液体发酵,应用硅胶柱色谱和高效液相色谱等方法进行分离和纯化,得到5个化合物,并用MS、NMR等方法对其结构进行解析,分别鉴定为N-乙酰酪胺(1)、N-乙酰色胺(2)、吡咯-2-甲酰胺(3)、Inthomycin C(4)和Inthomycin B(5)。对其抗真菌、细菌活性进行筛选,发现化合物4对金黄色葡萄球菌有抑制活性,化合物1和2对番茄灰霉病菌有抑制活性,化合物3对番茄早疫病菌有较强的抑制活性。     

极地海洋真菌赛氏曲霉活性成分研究

通过对菌株r DNA-ITS序列和系统发育多样性进行分析,鉴定该菌株为赛氏曲霉;对赛氏曲霉用大米培养基进行固体发酵培养,对其发酵产物采用有机溶剂萃取、硅胶柱色谱层析、反相ODS柱色谱层析、薄层色谱层析、Sephadex LH-20凝胶柱色谱层析和制备型高效液相色谱等分离纯化手段进行分离,得到7个单体化合物。对分离得到单体化合物采用质谱、核磁共振氢谱、核磁共振碳谱、二维核磁共振等现代波谱技术对其进行结构鉴定;对单体化合物的MIC值进行测定,其中化合物L-1对耐甲氧西林金黄色葡萄球(MRSA)、耐甲氧西林表皮葡萄球菌(MRSE)有一定的抑菌活性,对大肠杆菌有明显的抑菌活性。     

Kosinostatin, a major secondary metabolite isolated from the culture filtrate of Streptomyces violaceusniger strain HAL64

During a screening program, an actinomycete strain isolated from the Egyptian soil was investigated for its potential to show antimicrobial activity. The identification of this isolate was performed according to spore morphology and cell wall chemo-type, which suggested that this strain is a streptomycete. Further cultural, physiological characteristics and the analysis of the nucleotide sequence of the 16S rRNA gene (1480 bp) of this isolate indicated that this strain is identical to Streptomyces violaceusniger (accession number EF063682) and then designated S. violaceusniger strain HAL64. In its culture supernatant, this organism could produce one major compound strongly inhibits the growth of Gram-positive but the inhibition of Gram-negative indicator bacteria was lower. The antibiotic was separated by silica gel column chromatography and then purified on a sephadex LH-20 column and finally the purity was checked by HPLC. The chemical structure of the purified compound was determined using spectroscopic analyses (molecular formula of C33H32N2O10 and molecular weight of 617.21) and found to be identical to the kosinostatin, a quinocycline antibiotic which is known to be produced by Micromonspora sp. TP-A0468 (Igarashi et al., 2002) and to quinocycline B isolated from Streptomyces aureofaciens (Celmer et al., 1958). Although the antibiotic is known, the newly isolated strain was able to produce the antibiotic as a major product providing an important biotechnological downstream advantage.     

Synthesis and in vitro and in vivo evaluation of the 2-(6'methoxy-3',4'-dihydro-1'-naphtyl)-4H-3,1-benzoxazin-4- one as a new potent substrate inhibitor of human leukocyte elastase.

The title 2-vinyl-4H-3,1-benzoxazin-4-one has been synthesised and tested for inhibitory activity against human leukocyte elastase. The compound has shown activity both in vitro towards human sputum elastase and in vivo in an hemorrhagic assay.     

Isolation of a new antibiotic, alaremycin, structurally related to 5-aminolevulinic acid from Streptomyces sp. A012304

A new antibiotic, which is structurally related to 5-aminolevulinic acid, a precursor of heme biosynthesis, and named alaremycin, was isolated from the culture broth of an actinomycete strain through a random screening with the blue assay to detect the formation of anucleate cells in Escherichia coli. The producing strain was identified as Streptomyces sp. by morphological, physiological, chemical and genetic criteria. Alaremycin was purified from the culture supernatant by HP-20 hydrophobic-interaction chromatography, sequential solvent/water extraction in the acidic or alkaline pH range, and QMA cation-exchange chromatography. The chemical structure of alaremycin was determined as 5-acetamido-4-oxo-5-hexenoic acid by analyses of mass and NMR spectra. The antibacterial activity of alaremycin was enhanced in the presence of 5-aminolevulinic acid.     

Characterization of an endophytic whorl-forming Streptomyces from Catharanthus roseus stems producing polyene macrolide antibiotic

An endophytic whorl-forming Streptomyces sp. designated as TS3RO having antifungal activity against a large number of fungal pathogens, including Sclerotinia sclerotiorum, Rhizoctonia solani, Colletotrichum gloeosporioides, Cryphonectria parasitica, Fusarium oxysporum, Pyrenophora tritici-repentis, Epidermophyton floccosum, and Trichophyton rubrum, was isolated from surface-sterilized Catharanthus roseus stems. Preliminary identification showed that Streptomyces cinnamoneus subsp. sparsus was its closest related species. However, strain TS3RO could readily be distinguished from this species using a combination of phenotypic properties, 16S rDNA sequence similarity, and phylogenetic analyses. Thus, the whorl-forming Streptomyces sp. strain TS3RO is likely a new subspecies within the Streptomyces cinnamoneus group. Direct bioautography on a thin-layer chromatography plate with Cladosporium cucumerinum was conducted throughout the purification steps for bioassay-guided isolation of the active antifungal compounds from the crude extract. Structural elucidation of the isolated bioactive compound was obtained via LC-MS spectrometry, UV-visible spectra, and nuclear magnetic resonance data. It revealed that fungichromin, a known methylpentaene macrolide antibiotic, was the main antifungal component of TS3RO strain, as shown by thin-layer chromatography bioautography. This is the first report of an endophytic whorl-forming Streptomyces isolated from the medically important plant Catharanthus roseus.     

Partial purification and characterization of mouse peritoneal exudative macrophage elastase

Mouse peritoneal exudate macrophage elastase can be significantly purified with 60% recovery of the starting activity by affinity chromatography against SDS-treated alpha-elastin covalently linked to agarose beads. The enzyme has an apparent Mr of 26 500 based on SDS-acrylamide gel electrophoresis. Molecular sieving chromatography on Sephadex gel gives a Mr for macrophage elastase of 21 000--28 000. The enzyme is not inhibited by chloromethyl ketone inactivators specific for pancreatic and leukocyte elastase nor by phenylmethylsulfonyl fluoride. Macrophage elastase also does not bind to tritiated diisopropylphosphorofluoridate. The enzyme is inhibited by EDTA and thus appears to be a metallo-protease. Macrophage elastase is resistant to human alpha 1-proteinase inhibitor and to human and mouse alpha 2-macroglobulin. In view of its lack of susceptibility to these endogenous serum proteinase inhibitors, macrophage elastase may play an important role in physiological and pathological remodeling of connective tissues.     

Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes

Rat leukocyte elastase has been purified successively by AH-Sepharose Kappa-elastin affinity chromatography and by ion exchange chromatography on a carboxymethyl Sephadex resin. It has great similarities with human leukocyte elastase in its molecular weight, substrate specificity and inhibitory profile. The effect of rat leukocyte elastase inhibitors in influencing the chemotactic response of rat PMN to fMetLeuPhe has been compared to that of other proteinase inhibitors. The results indicated that oleoyl (Ala)2ProValCH2Cl, a specific inhibitor of human and rat leukocyte elastases and Eglin C, which also inhibits human and rat cathepsin G, are among the powerful inhibitors of rat PMN chemotaxis induced by the formyl oligopeptide. This suggests that these neutral proteinases, in addition to their known participation in connective tissue catabolism, could play a role in PMN locomotion and chemotaxis.     

Purification and preliminary characterization of human leukocyte elastasel.

Affinity chromatography permits the purification of 1–3 mg of human leukocyte elastase from the leukocytes contained in 500 ml of whole blood. Lysosomal granule proteins are extracted from polymorphonuclear leukocytes and subjected to chromatography on a column of elastin-Sepharose. Contaminating proteins are eluted with buffer containing 1 m NaCl and then elastase activity is eluted with buffer containing 8 m urea. The enzyme retains all of its esterase activity against N-t-BOC-l-alanine p-nitrophenyl ester after exposure to 8 m urea and retains 22% of its activity in the presence of 1% sodium dodecyl sulfate. In sodium dodecyl sulfate and 2-mercaptoethanol leukocyte elastase undergoes autolysis giving rise to several low molecular weight fragments. The molecular weight of the native enzyme is found to be 22.000 by both gel filtration and sodium dodecyl sulfate—acrylamide gel electrophoresis. A characteristic set of four isozymes is seen after acrylamide disc gel electrophoresis at pH 4.5. All bands are active against elastin and also contain carbohydrate by the periodic acid-Schiff stain. On the basis of stain intensity, the slower moving isozymes appear to be richest in carbohydrate. Active leukocyte elastase forms a complex with α₁-antitrypsin in a 1:1 molar ratio. The elastase must be enzymatically active for complex formation to occur.     

Isolation and characterization of tyrosinase produced by marine actinobacteria and its application in the removal of phenol from aqueous environment

The present study was focused on screening and characterization of tyrosinase enzyme produced by marine actinobacteria and its application in phenolic compounds removal from aqueous solution. A total of 20 strains were isolated from marine sediment sample and screened for tyrosinase production by using skimmed milk agar medium. Among 20 isolates, two isolates LK-4 and LK-20 showed zone of hydrolysis and these were taken for secondary screening by using tyrosiue agar medium. Based on the result of secondary screening LK-4 was selected for further analysis, such as tyrosinase assay, protein content and specific activity of the enzyme. The tyrosinase enzyme was produced in a SS medium and was partially purified by ammonium sulfate precipitation, dialysis and SDS PAGE. The isolate （LK-4） was identified as Streptomyces espinosus using 16S rRNA gene sequencing and named as ＂Streptomyces espinosus strain LK4 （KF806735）＂. The tyrosinase enzyme was immobilized in sodium alginate which was applied to remove phenolic compounds from water. The enzyme efficiently removed the phenolic compounds from aqueous solution within few hours which indicated that tyrosinasc enzyme produced by Streptomyces espinosus strain LK-4 can be potently used for the removal of phenol and phenolic compounds from wastewater in industries.     

Trifluoroacetyl tripeptides as potent inhibitors of human leukocyte elastase

Trifluoroacetylated peptides are much more potent inhibitors of human leukocyte elastase than the corresponding unblocked, acylated or benzyloxycarbonylated peptides. The most active compound was trifluoroacetyl-Val-Tyr-Val (Ki = 1.3 micron). A number of free and NH2-terminal-substituted peptides exhibited similar affinities for porcine pancreatic and human leukocyte elastase, indicating that these two enzymes must have similar specificity sites.     

The major fibrinolytic proteases of human leukocytes

The major fibrinolytic enzymes present in leukocyte granules and active at physiological pH have been identified. The fibrinolytic activity in extracts of leukocyte granules was bound to fibrinogen-Sepharose and eluted with 8.0 M urea. Two distinct zones of fibrinolytic activity were detected upon electrophoresis of leukocyte extracts on fibrinogen polyacrylamide gels, and both were qualitatively recovered in the 8.0 M urea eluate. Quantitatively, greater than 95% of the fibrinolytic activity was recovered in the urea eluate. Two major leukocyte proteases, elastase (EC 3.4.21.11) and cathepsin G (EC 3.4.21.-), were quantitatively recovered in the urea eluate. Both enzymes, when purified separately by affinity chromatography, were shown to: (a) possess fibrinolytic activity; (b) coincide in mobility and generate the two zones of fibrinolytic activity on fibrinogen polyacrylamide gels; and (c) quantitatively reconstitute the fibrinolytic activity of the leukocyte granules when combined at activity levels present in granular extracts. A highly significant correlation (r = 0.98) was found between the fibrinolytic activity and the sum of elastase and cathepsin G activity in leukocytes from five donors. Thus, elastase and cathepsin G are the major enzymes of the leukocyte fibrinolytic pathway, and fibrinogen-Sepharose chromatography may be used to obtain these enzymes.